PDS Biotechnology Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
PDS Biotechnology Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q3 2024.
  • PDS Biotechnology Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$10.7M, a 1.13% increase year-over-year.
  • PDS Biotechnology Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$40.6M, a 20.8% increase year-over-year.
  • PDS Biotechnology Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$42.9M, a 5.11% decline from 2022.
  • PDS Biotechnology Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$40.9M, a 141% decline from 2021.
  • PDS Biotechnology Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$16.9M, a 13.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$40.6M -$10.7M +$123K +1.13% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$40.7M -$8.33M +$3.21M +27.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$43.9M -$10.6M -$944K -9.77% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$42.9M -$10.9M +$8.24M +43.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$51.2M -$10.8M -$3.42M -46.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$47.8M -$11.5M -$5.72M -98.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$42M -$9.66M -$1.19M -14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$40.9M -$19.1M -$12.8M -203% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$28M -$7.42M -$463K -6.66% Jul 1, 2022 Sep 30, 2022 10-K 2024-03-28
Q2 2022 -$27.6M -$5.82M -$5.23M -888% Apr 1, 2022 Jun 30, 2022 10-K 2024-03-28
Q1 2022 -$22.3M -$8.47M -$5.42M -178% Jan 1, 2022 Mar 31, 2022 10-K 2024-03-28
Q4 2021 -$16.9M -$6.32M -$2.29M -56.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$14.6M -$6.96M -$3.06M -78.2% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-28
Q2 2021 -$11.6M -$589K +$2.34M +79.9% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-28
Q1 2021 -$13.9M -$3.05M +$937K +23.5% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-28
Q4 2020 -$14.8M -$4.03M +$151K +3.62% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$15M -$3.91M +$1.85M +32.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$16.8M -$2.93M +$957K +24.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$17.8M -$3.99M -$10.8M -158% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$7M -$4.18M -$2.36M -130% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$4.64M -$5.75M -$5.04M -709% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $400K -$3.89M -$3.32M -584% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $3.72M $6.82M +$7.55M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$3.84M -$1.82M +$12.1M +86.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$15.9M -$711K +$10.6M +93.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$26.5M -$568K +$12.9M +95.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$39.4M -$738K +$11.4M +93.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$50.9M -$13.9M -$4.39M -46.1% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-01
Q3 2017 -$46.5M -$11.3M -$522K -4.86% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$45.9M -$13.5M -$4.13M -44% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$41.8M -$12.2M -$3M -32.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 -$38.8M -$9.52M -$1.56M -19.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$37.3M -$10.8M -$629K -6.21% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$36.6M -$9.38M -$3.86M -69.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$32.8M -$9.17M -$4.7M -105% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$28.1M -$7.96M -$4.8M -152% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 -$23.3M -$10.1M -$6.61M -188% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 -$16.7M -$5.52M -$2.51M -83.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 -$14.2M -$4.47M -$1.96M -77.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 -$12.2M -$3.16M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$3.52M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-08
Q2 2014 -$3.01M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-08
Q1 2014 -$2.51M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.